PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $200 | -39.6% | 12,000 | 0.0% | 0.04% | -37.3% |
Q2 2023 | $331 | +19.9% | 12,000 | 0.0% | 0.07% | +9.8% |
Q1 2023 | $276 | +15.0% | 12,000 | -45.5% | 0.06% | +7.0% |
Q4 2022 | $240 | -99.9% | 22,000 | 0.0% | 0.06% | +21.3% |
Q3 2022 | $185,000 | +6.3% | 22,000 | 0.0% | 0.05% | +11.9% |
Q2 2022 | $174,000 | -66.6% | 22,000 | 0.0% | 0.04% | -58.8% |
Q1 2022 | $521,000 | -30.7% | 22,000 | 0.0% | 0.10% | -27.1% |
Q4 2021 | $752,000 | +92.8% | 22,000 | 0.0% | 0.14% | +75.0% |
Q3 2021 | $390,000 | -60.5% | 22,000 | 0.0% | 0.08% | -60.4% |
Q2 2021 | $987,000 | +73.2% | 22,000 | 0.0% | 0.20% | +57.8% |
Q1 2021 | $570,000 | +28.4% | 22,000 | 0.0% | 0.13% | +23.1% |
Q4 2020 | $444,000 | +3.3% | 22,000 | 0.0% | 0.10% | -7.1% |
Q3 2020 | $430,000 | +10.5% | 22,000 | 0.0% | 0.11% | -1.8% |
Q2 2020 | $389,000 | +151.0% | 22,000 | 0.0% | 0.11% | +70.1% |
Q1 2020 | $155,000 | 0.0% | 22,000 | 0.0% | 0.07% | +63.4% |
Q4 2019 | $155,000 | -24.0% | 22,000 | +29.4% | 0.04% | -30.5% |
Q3 2019 | $204,000 | -1.0% | 17,000 | 0.0% | 0.06% | -4.8% |
Q2 2019 | $206,000 | -15.9% | 17,000 | -12.8% | 0.06% | -19.5% |
Q1 2019 | $245,000 | +25.6% | 19,500 | -32.8% | 0.08% | +8.5% |
Q4 2018 | $195,000 | – | 29,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $20,647,000 | 6.08% |
Bain Capital Life Sciences Investors, LLC | 2,260,572 | $19,057,000 | 2.28% |
Kynam Capital Management, LP | 519,212 | $4,377,000 | 0.92% |
RTW INVESTMENTS, LP | 4,176,837 | $35,211,000 | 0.81% |
Tri Locum Partners LP | 199,500 | $1,682,000 | 0.46% |
Birchview Capital, LP | 38,000 | $320,000 | 0.22% |
Gratus Capital, LLC | 206,113 | $1,738,000 | 0.18% |
FARALLON CAPITAL MANAGEMENT LLC | 3,651,887 | $30,785,000 | 0.17% |
PDT Partners, LLC | 126,038 | $1,063,000 | 0.16% |
FOX RUN MANAGEMENT, L.L.C. | 40,683 | $343,000 | 0.13% |